Active ingredient : Osimertinib Osimertinib
Tagrisso, containing the active ingredient Osimertinib, is a targeted therapy used for the treatment of non-small cell lung cancer (NSCLC) that is positive for the epidermal growth factor receptor (EGFR) mutation. This innovative medication is designed to inhibit the growth of cancer cells by blocking specific signals that promote tumor growth and survival.
Couldn't load pickup availability
Free shipping and returns available on all orders!
We ship all US domestic orders within 5-10 business days
Tagrisso (Osimertinib) 80mg x 10 Tablets is a tablet supplied in 80mg. Use only under medical supervision.